Acute myeloid leukemia and novel biological treatments: monoclonal antibodies and cell-based gene-modified immune effectors.

@article{Tettamanti2013AcuteML,
  title={Acute myeloid leukemia and novel biological treatments: monoclonal antibodies and cell-based gene-modified immune effectors.},
  author={Sarah Tettamanti and Chiara Francesca Magnani and Andrea Biondi and Ettore Biagi},
  journal={Immunology letters},
  year={2013},
  volume={155 1-2},
  pages={43-6}
}
In the context of acute myeloid leukemia (AML) treatment, the interface between chemotherapy and immunotherapy is at present getting closer as never before. Scientific research is oriented in overcoming the main limits of actual chemotherapeutic regimens against AML, which still accounts for a considerable number of relapsed or resistant forms. A lot of investments have been done in the use of monoclonal antibodies (mAbs) and recently gene-modified immune cells have been considered as an… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 1 time over the past 90 days. VIEW TWEETS

From This Paper

Topics from this paper.
3 Citations
37 References
Similar Papers

References

Publications referenced by this paper.
Showing 1-10 of 37 references

Co - expression of a suicide gene in CAR - redirected T cells enables the safe targeting of CD 44 v 6 for leukemia and myeloma eradication

  • U Rupp, E Schoendorf-Holland, M Eichbaum, F Schuetz, I Lauschner, P Schmidt
  • Blood ASH
  • 2012

Diagnosis and management of acute myeloid leukemia in children and adolescents : recommendations from an international expert panel

  • U Creutzig, MM vandenHeuvel-Eibrink, B Gibson, MN Dworzak, S Adachi, E deBont
  • Blood
  • 2012

Diagnosis and management of acute myeloid leukemia in children and adolescents: recommendations from an international expert panel. Blood 2012;120:3187–205

  • U Creutzig, MM van den Heuvel-Eibrink, B Gibson, MN Dworzak, S Adachi, E de Bont
  • 2012
1 Excerpt

Similar Papers

Loading similar papers…